Afuco™ Anti-Human IL22 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-IL22 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. IL-22 is a recently described cytokine showing 23% amino acid identity with IL-10, and which has been previously shown to induce the production of acute phase proteins in liver and pancreas, suggesting a role in inflammatory responses. This antibody that binds to IL-22 is useful as modulators of a large panel of inflammatory disorders, including autoimmune diseases, cancer and sepsis. More particularly, anti-IL-22 antibodies are reported to inhibit arthritis in a mouse model.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-400CL |
| Pricing | Inquiry |
| Host | Human |
| Target | IL22 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |